DORADO, PR / ACCESS Newswire / January 29, 2026 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory affairs, quality, compliance, project management and technology ...
Heightened regulatory oversight of pharmaceutical distribution is reshaping South Africa’s logistics sector, placing ...
One Application Seeks European Commission Authorization; Other Application Would Facilitate Availability in Low- and Lower-Middle-Income Countries - - Both Applications Will Be Assessed in Parallel ...
ProImmune Ltd, a global leader in immunological reagents and services, announced the launch of Mastering Immunity 2026 - ...
The global, double-blinded phase 3 study enrolled 165 patients aged between 12 and 75 years and measured the time to onset ...
Early-stage regulatory strategy is becoming a powerful driver of speed, risk reduction, and commercial value in drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results